Day: November 27, 2020

Biogen and Sage enter into an agreement to jointly develop and commercialize zuranolone and SAGE-324 in the U.S.Biogen to receive exclusive license to develop and commercialize zuranolone and SAGE-324 outside of the U.S., excluding rights to zuranolone in Japan, Taiwan and South KoreaSage Therapeutics to receive $1.525 billion in cash comprised of an upfront payment of $875 million and a $650 million equity investment as well as potential milestone payments, profit sharing and royaltiesSage to host conference call Monday, November 30 at 8:00 a.m. ETBiogen to host conference call Monday, November 30 at 9:00 a.m. ETCAMBRIDGE, Mass., Nov. 27, 2020 (GLOBE NEWSWIRE) — Biogen Inc. (Nasdaq: BIIB) and Sage Therapeutics, Inc. (Nasdaq: SAGE) announced that they have executed a global collaboration and license agreement to jointly develop...

Senest 1. april 2021 tiltræder Peter Christiansen som sportsdirektør i F.C. København. Peter Christiansen vil referere til bestyrelsen for PARKEN Sport & Entertainment A/S.I perioden fra 2000 til 2005 spillede Peter Christiansen 120 kampe for F.C. København og har senest været ansat som sportschef i AGF A/S.Vedhæftet fil20-2020 Sportsdirektør

Aarhus, den 27. november 2020NASDAQ OMX Copenhagen A/SMeddelelse nr. 12 /2020Sportschef stopper i AGF A/SSportschef Peter Christiansen har i dag meddelt sin opsigelse, da han har underskrevet en aftale med F.C. København. AGF har på den baggrund ikke set andre muligheder end at suspendere ham med øjeblikkelig virkning.– Vi er meget ærgerlige over, at Peter Christiansen har valgt at stoppe i AGF. Han har haft stor betydning for den sportslige fremgang, vi har oplevet de seneste år, og jeg vil gerne takke ham for den store indsats, han har ydet for AGF. Vi skal nu finde en ny sportschef, og indtil vi har en permanent afløser på plads, har vi aftalt, at adm. direktør Jacob Nielsen overtager hans opgaver midlertidigt, siger Lars Fournais, bestyrelsesformand i AGF A/S.AGF har ikke yderligere kommentarer for nuværende.Med venlig hilsenAGF...

SAN FRANCISCO and TOKYO, Nov. 27, 2020 (GLOBE NEWSWIRE) — FibroGen, Inc. (Nasdaq: FGEN, CEO: Enrique Conterno, “FibroGen”) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) today announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) approved EVRENZO® (roxadustat) for the treatment of anemia of chronic kidney disease (CKD) in adult patients not on dialysis. This marks the second approval in Japan for roxadustat through the Astellas and FibroGen collaboration, after the therapy was approved and launched for use in adult patients with anemia of CKD on dialysis last year.“We are delighted roxadustat is now approved in Japan for adults with anemia of CKD not on dialysis, as it allows even more patients to access this important new treatment option,” said Bernhardt G. Zeiher, M.D.,...

TORONTO, Nov. 27, 2020 (GLOBE NEWSWIRE) — Pasinex Resources Limited (CSE: PSE) (FSE: PNX) (The “Company” or “Pasinex”) announces that they have reached an agreement with Cypress Development Corp. (“Cypress”) and Caliber Minerals Inc. to change the terms relating to the earn-in option agreement on the Gunman (formerly Spur) zinc exploration property in Nevada, USA.The agreement extends the deadline to complete the conditions to earn an initial 51% interest in the Gunman Project to December 31, 2022. It extends the deadline to complete the conditions to earn an additional 29% interest in the Gunman Project to December 31, 2024.As a condition precedent for the agreement’s effectiveness and as a binding and unconditional material obligation, Pasinex shall incur a minimum of US $200,000.00 of qualified exploration expenditures on or...

BONDUELLEA French SCA (Partnership Limited by Shares) with a capital of 56,942,095 Euros Head Office: La Woestyne, 59173 Renescure, France. Registered under number: 447 250 044 (Dunkerque Commercial and Companies Register)Villeneuve d’Ascq, November 27th,  2020Press ReleaseCombined Shareholders’ MeetingDecember 3rd, 2020Adjournment to December 17th, 2020In the absence of an order issued by the Government on the basis of Law No. 2020-1379 dated November 14th, 2020 on the state of health emergency in the context of Covid-19, making it possible to restore or adapt the conditions for holding shareholders’ meetings held as of December 1st, 2020, and taking into account the health context and the provisions decreed by the public authorities relating to the protection of populations, making it impossible for the shareholders to travel and for...

BONDUELLESociété en commandite par actions au capital de 56 942 095 €.Siège social : La Woestyne, 59173 Renescure.447 250 044 R.C.S. DunkerqueVilleneuve d’Ascq, le 27 novembre 2020CommuniquéASSEMBLEE GENERALE MIXTEDU 3 DECEMBRE 2020Ajournement au 17 décembre 2020En l’absence d’ordonnance prise par le Gouvernement sur la base de la loi n° 2020-1379 du 14 novembre 2020 sur l’état d’urgence sanitaire dans le contexte de la Covid-19, permettant de rétablir ou d’adapter les conditions de tenue des assemblées générales tenues à compter du 1er décembre 2020, et compte tenu du contexte sanitaire et des dispositions édictées par les pouvoirs publics relatifs à la protection des populations, conduisant à l’impossibilité pour les actionnaires de se déplacer et pour la société de recevoir et de réunir ses actionnaires physiquement, les actionnaires...

Harvia Plc, the global market leader in sauna and spa, has received the Internationalization Award granted by the President of the Republic of Finland Sauli Niinistö. Harvia Plc, which has been awarded as a growth company, has developed in 70 years from a local stove manufacturer into an internationally renowned sauna and spa brand whose products and solutions are sold in more than 80 countries. The company’s determined internationalization strategy began in the 1990s.

Harvia Oyj, sauna- ja spa-alan globaali markkinajohtaja, on saanut tasavallan presidentti Sauli Niinistön myöntämän kansainvälistymispalkinnon. Kasvuyrityksenä palkittu Harvia Oyj on kehittynyt 70 vuodessa muuramelaisesta kiukaiden valmistajasta kansainvälisesti tunnetuksi sauna- ja spa-brändiksi, jonka tuotteita ja ratkaisuja myydään yli 80 maassa. Yrityksen määrätietoisempi kansainvälistyminen alkoi jo 1990-luvulla.

Series  RIKV 21 0517 RIKV 21 0915Settlement Date  12/01/2020 12/01/2020Total Amount Allocated (MM)  4,900 0All Bids Awarded At (Price / Simple interest)  99.516 / 1.048 0.000 / 0.000Total Number of Bids Received  7 0Total Amount of All Bids Received (MM)  5,900 0Total Number of Successful Bids  6 0Number of Bids Allocated in Full  6 0Lowest Price / Highest Simple Interest Allocated  99.516 / 1.048 0.000 / 0.000Highest Price / Lowest Simple Interest Allocated  99.585 / 0.898 0.000 / 0.000Lowest Price / Highest Simple Interest Allocated in Full  99.516 / 1.048 0.000 / 0.000Weighted Average of Successful Bids (Price/Simple Interest)  99.547 / 0.981 0.000 / 0.000Best Bid (Price / Simple Interest)  99.585 / 0.898 0.000 / 0.000Worst Bid (Price / Simple Interest)  99.451 / 1.190 0.000 / 0.000Weighted...